Mucosa-associatedlym-
phoidtissue(MALT) 4 8, 57 ,
142
Multiplesclerosis 115
Mumpsvirus465, 466
diagnosis 641 , 64 4, 645
prevention 467
Murein 1 52, 153
Muscleinfections
653 – 654
Mutation
bacteria 17 0, 171 , 180
viruses389, 390
Mutationrate 171
Mxprotein 401
Mycelium 350
Mycetoma355, 372
diagnosis 652
Mycobacteria222, 262
nontuberculous(NTM)
27 1–2 72
clinicalpictures 271
culture 271
diagnosis 271
infectionscaused 272
morphology 271
therapy 271
seealsoMycobacterium
Mycobacterium222, 262
africanum 263
avium/intracellulare
complex 222
bovis 263
eyeinfections655,656,
657
leprae222, 269 – 271
clinicalpicture 270
diagnosis 27 0, 646 , 651
immunity 269 – 270
morphology 269
pathogenesis 269
tuberculosis222, 263
diagnosis
cardiovascularsys-
tem 647
nervoussystem 64 4,
645
respiratorytract 632
urogenitaltract635,
636
seealsoTuberculosis
bacteria(TB)
seealsoLeprosy;Myco-
bacteria;Tuberculosis;
Tuberculosisbacteria
(TB)
Mycogenicallergies
352 – 353
MycophytaseeFungi
Mycoplasma
hominis340, 341 , 342
diagnosis635, 636
pneumoniae 22 8, 34 0,
341 – 342
diagnosis 63 2,633,
647
Mycoplasmas6,228,
340 – 342
classification 340
clinicalpictures 341
culture 341
diagnosis 341
epidemiology 341 – 342
morphology 14 8,
340 – 341
pathogenesis 341
therapy 341
seealsoMycoplasma
Mycoses 353 – 357
cutaneous352,353,355,
37 2–3 74
diagnosis356, 652
host-pathogeninterac-
tions 353
opportunistic352,353,
354 – 355, 362 – 372
yeastmycoses
369 – 370
primary352,353,354,
358
subcutaneous352,355,
372
therapy352, 356
seealsospecificfungal
pathogens
Mycotoxicoses 353
Myelinbasicprotein(MBP)
142
Myeloidlineage 46
Myeloma69, 142
Myiasis 617
cutaneous 617
diagnosis 653
Myocarditis 647
&N
N-formimidoylthienamy-
cin 193
Naegleria(naegleriosis)
507
fowleri 507
diagnosis 646
Nailmycosis 374
Nairovirus 461
Naphtoquinones 533
Nasopharyngealcarcino-
ma 424
Naturalkiller(NK)cells85,
142 – 143
Necator(ancylostomosis)
580 – 582
americanus 580
clinicalmanifestations
582
control 582
diagnosis 58 2, 640
lifecycle 580 – 582
morphology 580
occurrence 580
therapy 582
Necrosis 392 – 393
structuralchanges
392 – 393
Necrotizingfasciitis 654
streptococcal 654
Necrotizingpneumonia
365, 634
Needlecomplex 17
Negativefactor(nef) 4 49
Neisseria222, 273 – 27 4,
647 , 655
gonorrheae222, 27 3,
274 – 276
culture 274
diagnosis 275
eyeinfections 656,
657
jointinfection 654
urogenitaltract635,
636, 637
morphology 27 4,
275
pathogenesis 274
penicillinresistance
276
seealsoGonorrhea
meningitidis 22 2,
27 3–2 74 , 27 6–2 78
antigenstructure
27 6–2 77
culture 276
diagnosis 277 , 644
morphology 2 75, 276
pathogenesis 277
sourcesofinfection
277
transmission 277
seealsoMeningitis
Neisseriaceae222, 274
Nematocera 60 6, 616
bitereactions 616
roleasvectors 616
684 MMucosa-associatedlymphoidtissue(MALT)
All rights reserved. Usage subject to terms and conditions of license
Kayser, Medical Microbiology © 2005 Thieme
All rights reserved. Usage subject to terms and conditions of license.